1Krammer S, Raff U. CA125 as an indicator of pleural metastases in breast cancer[J]. Anticancer Res, 1996, 16: 3165-3168
2Arjun MD, Thomas MD, Steven PD. Serum CA125 elevation and risk of clinical detection of cancer in asymptomatic postmenopausal women[J]. Cancer, 1999, 85(9): 2068-2072
3Duffy MJ, Shering S. CA15-3: a prognostic marker in breast cancer[J]. Int J Biol Markers, 2000, 15(4): 330-333
4Osborne CK. Steroid hormone receptors in breast cancer management[J]. Breast Cancer Res Treat, 1998, 51(3): 227-238
5Hung MC, Lan YK. Basic science of HER-2/neu: a review[J]. Semin Oncol, 1999, 26(4 Suppl 12): 51-59
3Coughlin S S,Ekwueme D U.Breast cancer as a global health concern[J].Cancer Epidemiology,2009,33:315.
4Héry C,Ferlay J,Boniol M,et al.Changes in breast cancer incidence and mortality in middle-aged and elderly women in 28 countries with Caucasian majority populations[J].Annals of Oncology,2008,19:1009.
5Harris L,Fritsche H,Mennel R,et al.American Society of Clinical Oncology 2007 Update of Recommendations for the Use of Tumor Markers in Breast Cancer[J].Journal of Clinical Oncology,2007,25:5287.
6Abd Hamid U M,Royle L,Saldova R,et al.A strategy to reveal potential glycan markers from serum glycoproteins associated with breast cancer progression[J].Glycobiology,2008,18:1105.
7Skates S J,Horick N K,Moy J M,et al.Pooling of case specimens to create standard serum sets for screening cancer biomarkers[J].Cancer Epidemiology,Biomarkers & Prevention,2007,16(2):334.
